Brief: China NT Pharma expects increase in net profit for six months ended 30 June 2017
10/07/2017 24:50
July 10 (Reuters) - China Nt Pharma Group Co Ltd 1011.HK :
* Group expects to record an increase in net profit by about
50 percent for six months ended 30 June 2017
* Expected increase is attributable to innovative drug Xi
Di Ke and brand-name drug Miacalcic which contributed to profit
of group
Source text for Eikon: urn:newsml:reuters.com:*:nHKSbSKzD3
Further company coverage: 1011.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY